Schonfeld Strategic Advisors LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$43,326
-96.2%
17,400
-81.0%
0.00%
-100.0%
Q3 2022$1,142,000
+232.0%
91,523
+539.9%
0.01%
+150.0%
Q1 2021$344,000
-19.8%
14,302
+74.3%
0.00%
-78.9%
Q3 2018$429,000
-2.9%
8,205
-31.2%
0.02%
-42.4%
Q1 2018$442,00011,9190.03%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders